close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

LLY

1,078.06

+0.48%↑

JNJ

205.77

-0.06%↓

ABBV

230.02

+2.55%↑

UNH

325.51

-0.8%↓

AZN

92.52

+1.3%↑

LLY

1,078.06

+0.48%↑

JNJ

205.77

-0.06%↓

ABBV

230.02

+2.55%↑

UNH

325.51

-0.8%↓

AZN

92.52

+1.3%↑

LLY

1,078.06

+0.48%↑

JNJ

205.77

-0.06%↓

ABBV

230.02

+2.55%↑

UNH

325.51

-0.8%↓

AZN

92.52

+1.3%↑

LLY

1,078.06

+0.48%↑

JNJ

205.77

-0.06%↓

ABBV

230.02

+2.55%↑

UNH

325.51

-0.8%↓

AZN

92.52

+1.3%↑

LLY

1,078.06

+0.48%↑

JNJ

205.77

-0.06%↓

ABBV

230.02

+2.55%↑

UNH

325.51

-0.8%↓

AZN

92.52

+1.3%↑

Home・Aandelen Lijst・Kala Pharmaceuticals Inc
Search

Kala Pharmaceuticals Inc

Gesloten

0.58 -1.69

Neutraal

Prijsupdate 23 dec 2025, 14:39 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

0.5

Max

0.63

Belangrijke statistieken

By Trading Economics

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+141.94% upside

Kala Pharmaceuticals Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 dec 2025, 23:54 UTC

Belangrijke Marktbewegers

Novo Nordisk ADRs Gain on FDA Approval of First GLP-1 in Pill Form

DJ

Lezen

22 dec 2025, 19:08 UTC

Acquisities, Fusies, Overnames

Correction to Alphabet to Buy Intersect Article

DJ

Lezen

22 dec 2025, 17:21 UTC

Acquisities, Fusies, Overnames

Alphabet to Buy Intersect for $4.75 Billion as AI-Investment Plans Grow -- Update

DJ

Lezen

22 dec 2025, 16:46 UTC

Acquisities, Fusies, Overnames

Alphabet to Buy Intersect for $4.75 Billion in Cash

DJ

Lezen

22 dec 2025, 23:50 UTC

Marktinformatie

Nikkei May Decline as Yen Rebounds -- Market Talk

DJ

Lezen

22 dec 2025, 23:42 UTC

Marktinformatie

Gold Hits Record High Amid Rising Geopolitical Risks -- Market Talk

DJ

Lezen

22 dec 2025, 22:31 UTC

Winsten

Zhejiang Sanhua Intelligent Controls: Higher Demand for Air-Conditioning Components Supported Results >002050.SZ

DJ

Lezen

22 dec 2025, 22:31 UTC

Winsten

Zhejiang Sanhua Intelligent Controls: Higher Demand for Refrigeration Supported Results >002050.SZ

DJ

Lezen

22 dec 2025, 22:30 UTC

Winsten

Zhejiang Sanhua Intelligent Controls Sees 2025 Net CNY3.87B, Up 25% on Year >002050.SZ

DJ

Lezen

22 dec 2025, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

22 dec 2025, 21:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

DJ

Lezen

22 dec 2025, 21:37 UTC

Acquisities, Fusies, Overnames

Capricorn: Project Is Contiguous to Capricorn's Golden Range, Fields Find Tenure

DJ

Lezen

22 dec 2025, 21:36 UTC

Acquisities, Fusies, Overnames

Capricorn to Pay A$500,000 Cash, A$4M in New Shares

DJ

Lezen

22 dec 2025, 21:35 UTC

Acquisities, Fusies, Overnames

Capricorn to Acquire Prospective Package From Tempest Minerals

DJ

Lezen

22 dec 2025, 21:35 UTC

Acquisities, Fusies, Overnames

Capricorn Metals to Buy Yalgoo Project Tenement Package for A$4.5M

DJ

Lezen

22 dec 2025, 20:54 UTC

Acquisities, Fusies, Overnames

Middle West Partners Buys Paul Stuart From Mitsui & Co.

DJ

Lezen

22 dec 2025, 20:52 UTC

Acquisities, Fusies, Overnames

HCL Technologies: HCLSoftware to Acquire Jaspersoft From Cloud Software Group >532281.BY

DJ

Lezen

22 dec 2025, 20:09 UTC

Marktinformatie

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

DJ

Lezen

22 dec 2025, 19:56 UTC

Marktinformatie

Crude Gains as U.S. Increases Actions Against Venezuela -- Market Talk

DJ

Lezen

22 dec 2025, 19:49 UTC

Acquisities, Fusies, Overnames

A Topsy-Turvy Year for Oracle and the Ellisons Will Bleed into 2026 -- Barrons.com

DJ

Lezen

22 dec 2025, 19:23 UTC

Marktinformatie

Mexico's Inflation Seen Easing in Early December -- Market Talk

DJ

Lezen

22 dec 2025, 19:23 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

22 dec 2025, 19:02 UTC

Marktinformatie

Global Energy Roundup: Market Talk

DJ

Lezen

22 dec 2025, 19:02 UTC

Marktinformatie

Precious Metals Climb to New Heights -- Market Talk

DJ

Lezen

22 dec 2025, 18:45 UTC

Marktinformatie

Canadian Trade-Exposed Industries At Forefront of Job Weakness -- Market Talk

DJ

Lezen

22 dec 2025, 18:30 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Intersect Selling Portion of Assets as Part of Alphabet Deal -- Market Talk

DJ

Lezen

22 dec 2025, 18:23 UTC

Acquisities, Fusies, Overnames

What Yogi Berra Would Say About the Talks to Take Over Warner Bros. Discovery -- Barrons.com

DJ

Lezen

22 dec 2025, 17:20 UTC

Marktinformatie

Health Care Roundup: Market Talk

DJ

Lezen

22 dec 2025, 17:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

DJ

Lezen

22 dec 2025, 17:06 UTC

Acquisities, Fusies, Overnames

Alphabet to Buy Intersect for $4.75B as AI-Investment Plans Grow -- Update

DJ

Lezen

Peer Vergelijking

Prijswijziging

Kala Pharmaceuticals Inc Prognose

Koersdoel

By TipRanks

141.94% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 1.5 USD  141.94%

Hoogste 1.5 USD

Laagste 1.5 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Kala Pharmaceuticals Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

2 ratings

0

Buy

2

Hold

0

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Kala Pharmaceuticals Inc - Dist in de afgelopen 3 maanden.

Financieel

$

Over Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc

Andere aandelen uit de sector

LLY

Eli Lilly and Co.

1,078.06

↑ +0.48%

JNJ

Johnson and Johnson

205.77

↓-0.06%

ABBV

AbbVie Inc

230.02

↑ +2.55%

UNH

UnitedHealth Group Inc

325.51

↓-0.8%

AZN

AstraZeneca PLC ADR

92.52

↑ +1.3%
help-icon Live chat